Publication | Closed Access

Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer

Advanced Breast CancerBreast OncologyOncologyEndocrine-related CancerNon-steroidal Aromatase InhibitorsMedicineGynecologyBreast CancerPharmacotherapyAromataseMenopausePharmacologyGynecology OncologyCancer ResearchWomen's HealthPostmenopausal Women